Canadian Cannabis News

Canopy Growth to Acquire Canadian Cannabis Producer – New Cannabis Ventures

Published

2 months ago

December 16, 2025

admin

Canopy Growth to Acquire Canadian Cannabis Producer – New Cannabis Ventures

Canopy growing to get MTL cannabis; The deal is expected to create Canada’s leading medical cannabis business and strengthen its ability to serve growing international demand.

_{This news release is a “designated news release” for purposes of Canopy Growth’s August 29, 2025 prospectus supplement to its short form base prospectus dated June 5, 2024.}

_{All financial amounts in this press release are expressed in Canadian dollars.}

The highly active business combination is expected to generate significant operating leverage of approximately $10 million within 18 months.
Strengthens Canopy Growth’s presence in Quebec, enabling expanded national distribution of MTL’s portfolio of high-quality, budget-friendly products²
MTL’s core management team is expected to join Canopy Growth to drive cultivation excellence and enhance the Company’s product quality and operational performance.
Assuming $0.91 per MTL share based on the closing price of Canopy Growth shares on the TSX as of December 12, 2025. Represents a 45% premium to MTL stock’s average 20-day VWAP on the CSE as of December 12, 2025.

SMITHS FALLS, Ontario and POINT CLAIRE, Quebec–( BUSINESS WIRE )–Canopy Growth Corporation (“Copy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) and MTL Cannabis Corp. (“MTL Cannabis” or “MTL”) (CSE: MTLC) (OTCQX: MTLNF) is pleased to announce that it has entered into a definitive arrangement agreement (the “Arrangement Agreement”) under which Canopy Growth will acquire all of the issued and outstanding common shares of MTL, as well as the shares of MTL (all indebtedness of MTL) and will pay the indebtedness. by MTL in a transaction valued at approximately $125 million on a fully diluted equity basis (the “Deal”) and approximately $179 million on an enterprise value (“TEV”) basis. Pursuant to the terms of the Agreement, each MTL shareholder (“MTL Shareholder”) will receive a fixed consideration for each MTL Share equal to:

MTL was founded by Quebec-based entrepreneurs and brothers, Richard and Michel Clemens, who built the company around a deep commitment to cultivating high-quality cannabis flower. The quality of hemp products produced through MTL’s disciplined, craft-based cultivation approach has earned national recognition, including being named Canada’s #1 Recommended Brand in the 2024 Brightfield Study. MTL brings proven operational excellence, loyal consumer demand and hemp production experience that works in the marketplace. Canopy Growth intends to leverage the expertise of the MTL team as it continues to enhance its cannabis product portfolio.

“MTL brings skilled operators, strong brands and a profitable business that will strengthen our leadership in the Canadian medical market and deepen our presence in key Canadian adult markets, including Quebec. Their cultivation expertise, combined with our national scale, allows us to improve product quality, expand supply and accelerate our path to building a more profitable, more competitive business, growing more competitively, growing Canada more competitively. long term,” said Luke Mongo, chief executive officer of Canopy Growth.

“MTL was built on the belief that high-quality flower grown with care and consistency will always earn the trust of consumers and patients. Joining Canopy Growth enables us to bring that philosophy to even more Canadians. Our respective portfolios are highly complementary and we see great opportunity to expand MTL’s reach through Canopy’s national relationships and Retail. what our team has built and we look forward to working with Canopy Growth to continue to elevate Canadian hemp,” said Richard Clemens, co-founder and chief cultivation officer of MTL Cannabis.

Original press release

Published by NCV Newswire

New Cannabis Ventures’ NCV Newswire aims to gather high-quality content and information about leading cannabis companies to help our readers filter through the noise and stay on top of the most important cannabis business news. The NCV Newswire is edited by an editor and is not, however, automated. Got a secret news tip? Get in touch.

Related Topics:Acquire Canadian Cannabis canopy growth Producer Ventures

Up Next

Trulieve Borrows $140 Million at 10.5% – New Cannabis Ventures

Don't Miss

MSOS Hit by Redemptions – New Cannabis Ventures

aawh

Cannabis Stocks Rally Begin 2026 Badly – New Cannabis Ventures

Published

5 days ago

January 30, 2026

admin

Cannabis Stocks Rocketed Higher in August – New Cannabis Ventures

Hemp stocks, as measured by the Global Hemp Stock Index, were quite volatile in 2024 and then again in 2025 as well. Although the index rose in December, it fell on the year. In January, the indicator decreased by 10.6%, reaching 5.89.

After collapsing 21.8% in late 2024 to 6.88 in Q4, the index fell heavily in Q1 and then marginally in Q2. The global hemp stock index, which now has 27 members, gained 53.0% in the third quarter but fell 14.2% in the fourth quarter, down 4.2% for the full year.

Since its peak in February 2021, the global hemp stock index is down 93.6% from a closing high of 92.48.

The 3 strongest names in January, each an MSO, were all up more than 4%;

January’s 3 weakest names are all down more than 26%;

Akanda (NASDAQ: WILL). -44.0%
iPower: (NASDAQ: IPW). -42.0%
RHYTHM (Name: RYM). -26.0%

We will summarize the performance of the index again in a month. In April, we historically combined the two articles, and we update here the other indexes that New Cannabis Ventures continues to maintain: the American Cannabis Operator Index, the Ancillary Cannabis Index, and the Canadian Cannabis LP Index.

American Hemp Operator Index

The ACOI sank in January, falling 12.5% to 11.53. In 2025, it increased by 57.7%, reaching 13.18. The large AdvisorShares Pure US Cannabis ETF ( MSOS ) fell 14.6% in January.

The strongest stock in January was Glass House Brands, which rose 4.0%. The weakest, Trulieve (OTC: TCNNF ), fell 20.5%.

The index will have nine members in February with the removals of Ascend Wellness (OTC: AAWH ) and Grown Rogue ( GRUSF ).

Auxiliary cannabis index

Ancillary commodities lost 5.9% in January as the index fell to 10.44. In 2025, the indicator decreased by 19.5%, reaching 11.09.

January’s strongest stock was Turning Point Brands, which rose 21.8%. The weakest iPower fell by 42.0%.

In February, the index will have the same ten members.

Canadian Hemp LP Index

Canadian LPs fell 4.9% in January as the index fell to 56.13. In 2025, the indicator increased by 17.8%, reaching 59.01.

Canada’s strongest LP in January was Simply Solventless Concentrates (TSXV: HASH ), up 28.6%. Tilray Brands (TSX: TLRY ) was the weakest, down 18.0%.

In February, the index will have the same thirteen members.

Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El

In this article.

Aaaaaah, WILL, Akanda, rise to health, blue, glass house brands, grown up bastard, grosf, HASH:, capacity, ipw:, power, rhythm, Scotts Miracle-Gro, Simply unsolvable, smg, tcnnf:, Tilray brands, TLRY:, TPB:, Trulul, to truly believe, Revolving brands

ACB

Canadian Cannabis Sales Lifted in November – New Cannabis Ventures

Published

2 weeks ago

January 23, 2026

admin

Canadian Cannabis Sales Grew Slowly in June – New Cannabis Ventures

On January 23, 2026 at 8:45 AM

Statistics Canada has released November retail sales for the country, with Cannabis sales are on the rise up 6.6% from October levels to C$477.9 million. This sequential increase is up 10.2% on a daily basis, driven by fewer days compared to the previous month. October, originally reported at C$451.7 million, was revised slightly lower to C$448.5 million. It was hit by a strike in British Columbia in October. Sales rose 4.6% in November from a year earlier, up from 8.3% in May, up from 7.5% in June and 6.2% in September. This was also lower than the 20.3% growth rate in August 2023 and better than the lowest growth rate in the previous year since the start of legalization, which started at -0.9% in September 2024 and then -1.6% in October due to the BC strike, and it was significantly down from the 9.1% growth in December. August’s record level was only 1.8% higher than last year’s index. Total sales are expected to grow 4.5% to C$5.39 billion in 2024 and 4.2% year-to-date in 2025.

An increase in the number of shops, as well as a fall in the prices of flowers that attract consumers from the illegal market, have boosted sales. In Ontario, the most populous province, sales fell 5.2% from October and 3% from a year ago. Alberta was down 5.5% from October and 2% from a year ago. British Columbia, which was down 55.0% sequentially in October and 54% year-over-year, was up 250% sequentially in October and 9% year-over-year, while Quebec was down 4.1% in October and 31% year-over-year.

December sales data will be released on February 20.

In this article.

ACB:, Alberta, Dawn cannabis, British Columbia, Canopy growth, CGC:, RELIGION:, Cronos Group:, high tide, heat, BREAD, Ontario, Organization chart, Quebec, SNDL:, sundial, Tilray brands, TLRY:, VFF:, Farms, MOGET:

280E

Cautious Cannabis Investors – New Cannabis Ventures

Published

3 weeks ago

January 15, 2026

admin

You are reading this week’s edition of New Cannabis Ventures, a weekly magazine we have published since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve, as well as links to the most important news of the week. We no longer email them like we used to, but post this and all newsletters on our website here.

friends,

With the first month of the year almost half over, the Global Hemp Stock Index rose 0.3% to 6.61. While that’s better than cash, it lags the S&P 500, which gained 1.2%, and notably the Russell 2000, which gained 6.9%.

The global hemp stock index has been in decline over the past five years, falling 4.2% in 2025, its best annual performance since a recent surge in 2020. The hemp industry is so down and should be rallying, but most bets on that outcome have lost money.

The index was recalculated at year-end, with three stocks exiting and two entering, leaving the index with 27 stocks. So far in 2026, 17 are up, with double-digit percentage gains, and 10 are down, including three that are down more than 20%. Here is a table that includes all the companies and some additional information:

The average market cap is $1.1 billion. MSOS is up 4.7% year-to-date, and the index contains 7 MSOs, all of which have gained. The last column shows that five of these seven have negative tangible book value, suggesting potential downside risk for those with significant debt.

I keep a close eye on 16 of the 27 names. Canopy Growth, Cresco Labs, Cronos Group, Curaleaf, GrowGeneration, Green Thumb Industries, Innovative Industrial Properties, WM Technology, Organigram, Chicago Atlantic Real Estate Finance, Scotts Miracle-TilrayrA BTrumsndce, Villa Verano. I’ve covered most of the others and written about RYTHM and SNDL on Seeking Alpha.

The drops include two recent additions that got me thinking more about inclusion rules. These two as well as others have very low market caps. They all met the minimum price rule and minimum average daily trading value criteria, and they are in the cannabis sector. The next rebalance, which will take place in March, may include some new rules.

The overall stock market is on the rise, but hemp stocks are still not catching the attention of investors. Shares in the index, up just 0.3% year to date, are trading near their 50-day and 150-day moving averages. MSOs are helping the market so far, while several stocks are hurting it. My model portfolio in the 420 Investor, which did very well in 2025, is outperforming the index so far in 2026. I’m very underweight MSOs relative to the index, own two, slightly overweight Canadian LPs (three names) and have a large overweight in ancillaries (four names). The model portfolio had 19% cash on 1/14.

The cannabis industry suffers from slow growth, increased competition, a slowdown in adult-use states, an uncertain regulatory environment at the federal level, and many unfair taxes (280E) Hopefully things will improve in 2026.

Sincerely,

Alan:

New Cannabis Ventures publishes curated articles as well as exclusive news. Here is what we published last week.

Exclusives

Michigan hemp sales were soft in December

Financial statements

Tilray Brands reports cannabis revenue up 5% in Q2

Follow Alan for real-time updates X.com:. Share and discover industry news with like-minded people on the largest group of cannabis investors and entrepreneurs LinkedIn:.

View: Public Hemp Company Revenue and Earnings Trackingwhich ranks the highest-earning hemp stocks.

Stay on top of the most important communications from public companies by watching what’s coming cannabis investor calendar.